FDG-PET and MIBI-Tc SPECT as follow-up tools in a patient with cardiac sarcoidosis requiring a pacemaker.
A 63-year-old man presented with recent-onset symptoms secondary to third-degree atrio-ventricular block, for which a dual-chamber pacemaker was inserted. Additional investigations resulted in the diagnosis of cardiac sarcoidosis. FDG-PET and MIBI-technetium SPECT were used as follow-up tools for monitoring active granulomatous myocardial infiltration.
Smedema
J P
JP
Lazaron Heart Clinic, Netcare N1 City Hospital, Goodwood. jansmedema@hotmail.com
White
L
L
Klopper
A J
AJ
D054537:Atrioventricular Block / Q000000981:diagnostic imaging / Q000209:etiology / Q000628:therapy*; D009202:Cardiomyopathies / Q000150:complications / Q000000981:diagnostic imaging* / Q000628:therapy; D019788:Fluorodeoxyglucose F18; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D010138:Pacemaker, Artificial; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D012507:Sarcoidosis / Q000150:complications / Q000000981:diagnostic imaging* / Q000628:therapy; D013256:Steroids / Q000627:therapeutic use; D017256:Technetium Tc 99m Sestamibi; D015899:Tomography, Emission-Computed, Single-Photon; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D019275:Radiopharmaceuticals; D013256:Steroids; D019788:Fluorodeoxyglucose F18; D017256:Technetium Tc 99m Sestamibi; D008727:Methotrexate